Politics
Economy
World News
Stock
Editor’s Pick

Home Editor's Pick RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025

June 4, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post

Operational Update

next post

China’s Breakthrough in Uranium Seawater Extraction Boosts Efficiency by 40 Times

Related Posts

Silver Price Surges to US$36, Marking 13 Year...

June 6, 2025

Auto Industry Takes Hit as China’s Rare Earths...

June 6, 2025

Retraction of Lo Herma Scoping Study Statements

June 6, 2025

Metals Focus: Gold to Average US$3,210 in 2025...

June 6, 2025

Prismo Metals Appoints Gordon Aldcorn as President

June 6, 2025

Justin Huhn: Uranium Game On — Supply “Mirage,”...

June 6, 2025

Should You Invest in Silver Bullion?

June 6, 2025

Trump Admin Strips “Safety” from AI Oversight Institute...

June 6, 2025

In-fill RC Drilling at Kamperman Confirms High-Grade Gold

June 6, 2025

Offer Booklet – Non-Renounceable Entitlement Offer

June 6, 2025

Join The Exclusive Subscription Today And Get Premium Articles For Free

Your name

Your email

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent Posts

Prismo Metals Appoints Gordon Aldcorn as President

June 6, 2025
Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow

June 6, 2025
Retraction of Lo Herma Scoping Study Statements

June 6, 2025
Auto Industry Takes Hit as China’s Rare Earths Export Controls Impact Supply Chains

June 6, 2025
Silver Price Surges to US$36, Marking 13 Year High

June 6, 2025

About us
Contact us
Privacy Policy
Terms & Conditions

Copyright © 2025 rightchoiceinvestors.com | All Rights Reserved

Politics
Economy
World News
Stock
Editor’s Pick